Inguscio C, Carton F, Cisterna B, Rizzi M, Boccafoschi F, Tabaracci G
Eur J Histochem. 2024; 68(3).
PMID: 39252536
PMC: 11445695.
DOI: 10.4081/ejh.2024.4106.
Ozalp O, Goksu O, Toru H, Altay M, Sindel A
Eur J Med Res. 2024; 29(1):359.
PMID: 38978136
PMC: 11232170.
DOI: 10.1186/s40001-024-01907-3.
Pereira-Silva M, Hadad H, de Jesus L, Oliveira M, de Almeida J, Nimia H
Clin Oral Investig. 2024; 28(2):151.
PMID: 38360985
DOI: 10.1007/s00784-024-05547-z.
Szklener K, Rudzinska A, Juchaniuk P, Kabala Z, Mandziuk S
Int J Mol Sci. 2023; 24(6).
PMID: 36982352
PMC: 10049472.
DOI: 10.3390/ijms24065279.
Di Fede O, Del Gaizo C, Panzarella V, La Mantia G, Tozzo P, Di Grigoli A
J Clin Med. 2022; 11(18).
PMID: 36142954
PMC: 9502994.
DOI: 10.3390/jcm11185307.
Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan N, Mayer B, Hussein H, Zolk O, Peter J
Cochrane Database Syst Rev. 2022; 7:CD012432.
PMID: 35866376
PMC: 9309005.
DOI: 10.1002/14651858.CD012432.pub3.
Factors Exacerbating Clinical Symptoms and CT Findings in Patients with Medication-Related Osteonecrosis of the Jaw Receiving Conservative Therapy: A Multicenter Retrospective Study of 53 Cases.
Kojima Y, Soutome S, Otsuru M, Hayashida S, Sakamoto Y, Sawada S
Int J Environ Res Public Health. 2022; 19(13).
PMID: 35805513
PMC: 9265462.
DOI: 10.3390/ijerph19137854.
Comparative Evaluation of pH and Cytotoxicity of Zinc Oxide-Ozonated Eugenol and Conventional Zinc Oxide Eugenol as Endodontic Sealers.
Ravivarman C, Jeyasenthil A, Ajay R, Nilofernisha N, Karthikeyan R, Rajkumar D
J Pharm Bioallied Sci. 2020; 12(Suppl 1):S73-S77.
PMID: 33149434
PMC: 7595563.
DOI: 10.4103/jpbs.JPBS_21_20.
Ozone at low concentrations does not affect motility and proliferation of cancer cells in vitro.
Costanzo M, Romeo A, Cisterna B, Calderan L, Bernardi P, Covi V
Eur J Histochem. 2020; 64(2).
PMID: 32241095
PMC: 7137928.
DOI: 10.4081/ejh.2020.3119.
Clinical utility of ozone therapy in dental and oral medicine.
Suh Y, Patel S, Kaitlyn R, Gandhi J, Joshi G, Smith N
Med Gas Res. 2019; 9(3):163-167.
PMID: 31552882
PMC: 6779001.
DOI: 10.4103/2045-9912.266997.
The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure.
Galie M, Covi V, Tabaracci G, Malatesta M
Int J Mol Sci. 2019; 20(16).
PMID: 31426459
PMC: 6720777.
DOI: 10.3390/ijms20164009.
Intra-tumoral treatment with oxygen-ozone in glioblastoma: A systematic literature search and results of a case series.
Megele R, Riemenschneider M, Dodoo-Schittko F, Feyrer M, Kleindienst A
Oncol Lett. 2018; 16(5):5813-5822.
PMID: 30344733
PMC: 6176341.
DOI: 10.3892/ol.2018.9397.
Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma.
Rugani P, Walter C, Kirnbauer B, Acham S, Begus-Nahrman Y, Jakse N
Dent J (Basel). 2018; 4(4).
PMID: 29563474
PMC: 5806952.
DOI: 10.3390/dj4040032.
Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol.
Ramaglia L, Guida A, Iorio-Siciliano V, Cuozzo A, Blasi A, Sculean A
Clin Oral Investig. 2018; 22(2):597-615.
PMID: 29332231
DOI: 10.1007/s00784-017-2325-6.
Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan N, Mayer B, Hussein H, Zolk O
Cochrane Database Syst Rev. 2017; 10:CD012432.
PMID: 28983908
PMC: 6485859.
DOI: 10.1002/14651858.CD012432.pub2.
The effects of ozone application on genotoxic damage and wound healing in bisphosphonate-applied human gingival fibroblast cells.
Akdeniz S, Beyler E, Korkmaz Y, Yurtcu E, Ates U, Araz K
Clin Oral Investig. 2017; 22(2):867-873.
PMID: 28699091
DOI: 10.1007/s00784-017-2163-6.
Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates-Preliminary data: Medical ozone gas insufflation in treating ONJ lesions.
Ripamonti C, Maniezzo M, Boldini S, Pessi M, Mariani L, Cislaghi E
J Bone Oncol. 2016; 1(3):81-7.
PMID: 26909261
PMC: 4723354.
DOI: 10.1016/j.jbo.2012.08.001.
Comparison of Low-Level Laser Therapy versus Ozone Therapy in the Treatment of Oral Lichen Planus.
Kazancioglu H, Erisen M
Ann Dermatol. 2015; 27(5):485-91.
PMID: 26512161
PMC: 4622881.
DOI: 10.5021/ad.2015.27.5.485.
The use of ozone in the prevention of osteoradionecrosis of the jaw.
Batinjan G, Filipovic Zore I, Vuletic M, Rupic I
Saudi Med J. 2014; 35(10):1260-3.
PMID: 25316473
PMC: 4362119.
Ozone treatment of alveolar bone in the cape chacma baboon does not enhance healing following trauma.
Kotze M, Butow K, Olorunju S, Kotze H
J Maxillofac Oral Surg. 2014; 13(2):140-7.
PMID: 24822005
PMC: 4016407.
DOI: 10.1007/s12663-013-0471-1.
